Vycor Medical (VYCO) Cash from Operations Growth (3y) (2013 - 2026)
Vycor Medical (VYCO) Cash from Operations Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn | 4.78% |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn | 9.30% |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn | 1.51% |
| 4 | Boston Scientific | 68.63 Bn | 67.18 Bn | 3.61 Bn | 22.35% |
| 5 | Edwards Lifesciences | 48.43 Bn | 44.76 Bn | 1.29 Bn | -48.14% |
| 6 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn | 50.11% |
| 7 | GE HealthCare Technologies | 28.14 Bn | 25.85 Bn | 1.98 Bn | -14.75% |
| 8 | Smith & Nephew | 26.89 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 24.25 Bn | 21.12 Bn | 2.07 Bn | 0.50% |
| 10 | Vycor Medical | 2.34 Mn | 2.16 Mn | 375,153.00 | 59.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.24% |
| Dec 31, 2025 | 47.00% |
| Sep 30, 2025 | 1.91% |
| Jun 30, 2025 | 54.07% |
| Mar 31, 2025 | 30.10% |
| Dec 31, 2024 | -47.62% |
| Sep 30, 2024 | 29.42% |
| Jun 30, 2024 | -0.17% |
| Mar 31, 2024 | 27.14% |
| Dec 31, 2023 | 43.08% |
| Sep 30, 2023 | 55.06% |
| Jun 30, 2023 | 32.35% |
| Mar 31, 2023 | 39.44% |
| Dec 31, 2022 | -107.89% |
| Sep 30, 2022 | -80.90% |
| Jun 30, 2022 | -31.70% |
| Mar 31, 2022 | -63.40% |
| Dec 31, 2021 | 6.81% |
| Sep 30, 2021 | -20.09% |
| Jun 30, 2021 | 41.28% |